CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 652 enrolled / 652 target
Drug / intervention
ALTAbehavioral
Likely dose
Not stated in record
Key inclusion· 7
  • Self-identify as Latino
  • Age 18 years or older
  • Receiving care in a safety-net primary care practice
  • Uncontrolled hypertension documented in EHR on at least two visits in past year (average BP ≥140/90 mmHg)
Key exclusion· 5
  • Unable to comply with study protocol
  • Participation in other hypertension-related clinical trials
  • Significant psychiatric comorbidity or substance abuse documented in EHR
  • Plan to discontinue care at their practice within next 12 months

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03713515
NCT03713515Phase 4CompletedOn Track (9.7/mo)Completion was 25mo ago

Bridging the Evidence-to-practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-level Adherence Intervention Into Safety Net Practices

NYU Langone Health·interventional·Posted Oct 19, 2018·Updated Jun 10, 2026

In Brief

A Phase 4 clinical trial evaluating ALTA for Hypertension. Completed, enrolled 652 participants across 1 site.

Detailed Summary

The proposed project will address this evidence-to-practice gap by evaluating the effect of practice facilitation (PF) of the intervention implementation fidelity (primary outcome) and clinical measures at 12 months (secondary outcomes).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 19, 2018
Enrollment StartDec 1, 2020
Primary CompletionMay 30, 2024
Study CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.7 years ago

Arms & Interventions

Practice Faciliationexperimental

Will be supported by a practice facilitator

Behavioral: ALTA
Usual Careno_intervention

Using a stepped wedge design, all practice sites begin as part of the Usual Care (UC) control condition and will receive standard hypertension management that is part of the current clinic procedure. No practice facilitation will occur at this time.

Interventions

ALTAbehavioral

The study will involve each site starting with the usual care phase, followed by a period of 6 months during which practice facilitators will conduct the pre-implementation evaluation (e.g., workflow analysis, environmental scan), refine the practice facilitation strategies that will be used in the implementation phase, and train staff in the Advancing Medication Adherence for Latinos with Hypertension through a Team-based Care Approach (ALTA) intervention model. ALTA is an efficacious systems-level intervention designed to help patients improve their ability to take their high blood pressure medications and control their blood pressure. Practices and the Project ALTA team will work together to implement the ALTA model into routine care to improve blood pressure control and medication adherence in Latinx patients.